Evolution of the tumor oxygenation and perfusion at the early stage of the treatment with SU5416, an inhibitor of Flk-1 tyrosine kinase.

Poster (Scientific congresses and symposiums)

Ansiaux, Réginald; Baudelet, Christelle; Cron et al.

2006 • Proc. Intl. Soc. Mag. Reson. Med.

Permalink
https://hdl.handle.net/2268/113273

Evolution of the tumor oxygenation and perfusion at the early stage of the treatment with SU5416, an inhibitor of Flk-1.pdf

Publisher postprint (41.95 kB)

All documents in ORBi are protected by a user license.

Disciplines :

Oncology

Author, co-author :

Ansiaux, Réginald

Baudelet, Christelle

Cron

MARTINIVE, Philippe ; Biomedical Magnetic Resonance Unit, Catholic University of Louvain, Woluwe, Brussels, Belgium

DEWEVER, Julie

GREGOIRE, Vincent

FERON, Olivier

Gallez

Language :

English

Title :

Evolution of the tumor oxygenation and perfusion at the early stage of the treatment with SU5416, an inhibitor of Flk-1 tyrosine kinase.

Publication date :

May 2006

Event name :

Proc. Intl. Soc. Mag. Reson. Med.

Event date :

du 06 au 12 mai 2006

Audience :

International

Available on ORBi :

since 02 March 2012

Number of views

23 (1 by ULiège)

Number of downloads

64 (1 by ULiège)